Amiliana M. Soesanto
Departemen Ilmu Penyakit Jantung Dan Pembuluh Darah RSJP Harapan Kita/Fakultas Kedokteran Universitas Indonesia Jakarta.

Published : 30 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 30 Documents
Search

Pemeriksaan Hemodinamik Ekokardiografi pada Kasus Kegawatan dan Kritikal Jantung Amiliana M Soesanto
Jurnal Kardiologi Indonesia Vol. 33, No. 3 Juli - September 2012
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v33i3.316

Abstract

Akhir-akhir ini pemeriksaan ekokardiogra? semakin berperan untuk menilai kondisi hemodinamik pasien gawat dan kritis untuk membantu penatalaksanaan dan perawatan intensif agar lebih terarah dan tepat. Secara umum pemeriksaan ekokardiogra? yang dilakukan pada kasus kegawatan dan kritikal adalah pemeriksaan ekokardiogra? yang singkat, terfokus, dan sederhana agar dapat menjawab pertanyaan spesi?k mengenai kondisi hemodinamik pasien untuk kepentingan penatalaksanaan. Walaupun demikian, beberapa kondisi kritis memerlukan pemeriksaan ekokardiogra? yang lebih rinci dan akurat. 
Penilaian Fungsi Ventrikel Kanan (2) Amiliana M Soesanto
Jurnal Kardiologi Indonesia Vol. 30, No. 3 September - Desember 2009
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v30i3.319

Abstract

Pada edisi sebelumnya telah dibicarakan beberapa cara penilaian praktis dan sederhana terhadap fungsi ventrikel kanan. Selanjutnya pada dalam artikel ini akan diuraikan kembali cara pengukuran funfsi ventrikel kanan yang agak lebih "advanced" yang mungkin hanya terbatas penggunaannya untuk kepentingan kasus khusus atau penelitian. Artikel ini dimaksudkan bukan untuk menjelaskan tentang teori dan latar belakang.
Tips Dan Trik: Mengenali Tamponade Rina Ariani; Amiliana M Soesanto
Jurnal Kardiologi Indonesia Vol. 34, No. 3 Juli - September 2013
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v34i3.343

Abstract

Tamponade merupakan kondisi klinis mengancam jiwa dimana fungsi jantung terganggu oleh penekanan dari ruang pericardium, baik oleh cairan, massa, bekuan darah, ataupun kombinasi antara ketiganya. Fisiologi tamponade terjadi akibat terganggunya hemodinamik akibat peningkatan tekanan intra pericardium sehingga mengganggu pengisian ruang jantung. Tamponade dapat terjadi akibat adanya volume efusi yang cukup besar atau terbentuknya efusi dalam waktu yang singkat. Perlu diingat bahwa efusi yang besar dapat tidak menimbulkan tamponade bila terakumulasi bertahap sehingga memungkinkan rongga perikard meregang dan beradaptasi. Harus pula digaris bawahi diagnosis tamponade merupakan diagnosis berdasarkan klinis namun ekokardiografi seringkali dapat mengenali adanya tamponade dengan lebih dini.
Myxoma Atrium Kiri pada Kehamilan: Tantangan dalam Diagnosis dan Tatalaksana Rony Mario Candrasatria,; Bambang Budi Siswanto; Nani Hersunarti; Rarsari Soerarso; BRM Ario S. Kuncoro; Amiliana M. Soesanto
Jurnal Kardiologi Indonesia Vol. 35, No. 1 Januari - Maret 2014
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v35i1.373

Abstract

Primary tumors of the heart are rare where myxomas predominate as the most common type of primary cardiac tumors in all age groups. Even rarer, the incidence of myxomas during pregnancy is reported extremely low in the medical literature. The hemodynamic changes during pregnancy play an important role in influencing the clinical manifestation. The management is vary, depending on the week of gestation and risk assessment for both the mother and baby.We report a case of left atrial myxoma in 33-34 weeks of pregnancy. After judicious consideration, the patient was planned to have caesarian section at the full term pregnancy that will be followed one week after by tumor resection.
Ekokardiografi Transtorakal pada Deteksi Awal Gangguan Fungsi Katup Mitral Prostetik Hasanah Mumpuni; Amiliana M Soesanto
Jurnal Kardiologi Indonesia Vol. 34, No. 4 Oktober - Desember 2013
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v34i4.388

Abstract

Pemeriksaan ekokardiografi transtorakal (TTE)merupakan cara yang masih diandalkandalam skrening gangguan fungsi katup mitralprostetik (prosthetic mitral valve – PMV),karena ekokardiografi transesopagus (TEE) tidakdapat dikerjaan secara rutin. Tetapi adanya gambaranacoustic shadow sangat mengganggu pada deteksidisfungsi PMV dengan pemeriksaan TTE terutamaadanya regurgitasi.
Myxoma Atrium Kiri dengan Regurgitasi Trikuspid: Patofisiologi, Diagnosis dan Tata Laksana Prima Almazini; Bambang Budi Siswanto; Nani Hersunarti; Rarsari Soerarso; Amiliana M Soesanto
Jurnal Kardiologi Indonesia Vol. 36, No. 1 Januari - Maret 2015
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v36i1.438

Abstract

Cardiac myxomas are the most common primary cardiac tumors. Myxoma are more common in women. Clinical manifestations can mimic many cardiac and noncardiac conditions. Transthoracic echocardiography (TTE) is the gold standard method in the diagnosis of cardiac myxoma. The management of cardiac myxoma are medical therapy for the treatment of associated conditions and surgical removal as the definitive treatment.
Pengalaman Awal Tindakan MitraClip di Pusat Jantung Nasional Harapan Kita, Jakarta Prima Almazini; Nani Hersunarti; Rarsari Soerarso; Bambang Budi Siswanto; Doni Firman; Amiliana M Soesanto
Jurnal Kardiologi Indonesia Vol. 36, No. 2 April - Juni 2015
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v36i2.462

Abstract

Background: Percutaneous mitral valve repair (PMVR) with MitraClip is considered as an optional treatment for patients with significant MR who are high risk for having surgery. This novel therapy is less invasive, safe, and effective for MR reduction, and hence improve symptoms of heart failure, as well as reverse left ventricle remodeling. The purpose of this study was to report the early experience of Mitraclip procedure for treating significant MR at the National Cardiovascular Center Harapan Kita.Methods: This retrospective study was conducted at National Cardiovascular Center Harapan Kita Hospital, Jakarta. The data was retrieved from computerized database and medical records from February 2014 to January 2015, and then analyzed with SPSS.Results: A total of 6 patients with age 51 - 75 years old, underwent MitraClip procedure. Of all patients, the MR were severe in 5 patients and moderate in 1 patient. One was female and 5 were male. Among these patients, 2 were degenerative MR and 6 were functional MR. Two patients were treated with single MitraClip and 4 patients required double MitraClip. Post proccedure, there was reduction of MR to mild was achieved in 2 patients and to moderate in 4 patients. The left ventricular end diastolic dimension decreased from 66 ± 6.5 mm at baseline to 59 ± 7.3 mm (p=0.04) and end systolic dimensions decreased from 50 ± 10.6 mm at baseline to 48 ± 10.0 mm before discharge (p=0.27) as evaluated from predischarge echocardiography. At one month after procedure, 2 patients were in New York Heart Association (NYHA) functional class I and 4 patients were in class II. In-hospital mortality was 0%. Only 1 patient was re-hospitalized after procedure due to heart failure.Conclusion: From our early experience, MitraClip was considered an effective and safe option for patients with functional and degenerative MR who are at high risk for open-heart surgery. Left ventricle dimension, NYHA functional class, MR reduction, and re-hospitalization rate were improved after procedure.
Regurgitasi Mitral Kronik: Waktu Intervensi yang Optimal Estu Rudiktyo; Amiliana M. Soesanto
Jurnal Kardiologi Indonesia Vol. 36, No. 2 April - Juni 2015
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v36i2.465

Abstract

Chronic mitral regurgitation is commonly encountered valve disease. In this disease, there is volume overload on the left ventricle leading to left ventricle dilatation and dysfuction. Surgical or percutaneous intervention can improve prognosis, however optimal timing of intervention still controversial. In the past, timing of intervention was based solely on symptoms and left ventricle function. There have been recent advances in our knowledge, diagnosis, and treatment of mitral regurgitation. All of these advances have provided an incentive to change the indication for timing of operations in patients with mitral regurgitation, setting a new paradigm of an early operation before the onset of ventricular dysfunction. In this article we will outline these newer advances and provide recommendations regarding optimal timing of intervention for mitral regurgitation.
Antibiotic Susceptibility among Infective Endocarditis Population: Syndromic Antibiogram Evaluation at Indonesian National Cardiovascular Center Indrawati, Lilik; Sugianli, Adhi Kristianto; Prakoso, Baskoro Justicia; Gunawan, Adrian; Soerarso, Rarsari; Soesanto, Amiliana M.; Dewi, Andaru Dahesih
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 31 No. 1 (2024)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v31i1.2223

Abstract

Infective Endocarditis (IE) is a life-threatening disease with a high mortality rate (25%). Laboratory approaches to support the diagnosis of IE especially blood and/or cardiac vegetation culture, are crucial for providing definitive therapy. However, negative culture is frequently observed, therefore empirical use of antibiotics seems unavoidable and may lead to increasing antimicrobial resistance. This study aims to observe the prevalence of antibiotic susceptibility among the IE population using the WISCA approach. This retrospective study observed medical record data of all inpatients diagnosed with IE according to ICD-10 at Cardiovascular Center Harapan Kita Hospital (NCCHK) between January 2018 and December 2022. Patient data were combined with bacterial identification and antibiotic susceptibility test data from the laboratory information system, and evaluated based on period (year). A total of 67,858 inpatients and 1.1% (n=772) were diagnosed with IE. Successful culture growth (blood and/or cardiac vegetation specimen) was between 36.8% and 70% annually. Streptococcus viridans group (82/237, 34.6%) and Coagulase-negative Staphylococci (57/237, 24.1%) were dominantly observed among the IE population. Low susceptibility among Penicillin (34.3%) towards Gram-positive bacteria, as first-line treatment option in IE. Meanwhile, high susceptibility range was observed in Ceftriaxone (95.7%), Gentamicin (80.4%), Rifampicin (84.4%), and Vancomycin (98.7%) as second-line treatment in IE. Despite the low prevalence, the occurrence of antimicrobial resistance in IE has become a priority concern. Continuing the syndromic antibiogram is mandatory to assist the trend of empirical antibiotic usage and refine the established local treatment guidelines.
Does Chronic Inflammation Play a Role in Rheumatic Mitral Valve Restenosis after Percutaneous Transvenous Mitral Commissurotomy? Butarbutar, Maruli; Soesanto, Amiliana M.; Firman, Doni; Ariani, Rina; Alkatiri, Amir Aziz; Wicaksono, Sony Hilal
Jurnal Kardiologi Indonesia Vol 43 No 3 (2022): Indonesian Journal of Cardiology: July - September 2022
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1398

Abstract

Background: Mitral valve restenosis is defined as decreased mitral valve area (MVA) <1.5 cm2 or decreased MVA >50% after PTMC. It is time-dependent and associated with major adverse cardiovascular events (MACE), such as congestive heart failure, cardiac death, mitral valve replacement, and redo PTMC. The mechanism is not yet known; however, chronic inflammation may have a role. This research aims to determine the association between chronic inflammation and mitral valve restenosis after PTMC. Methods: A total of 40 patients with mitral valve stenosis who underwent successful PTMC were matched and classified into restenosis/case group (n=20) and no restenosis/control group (n=20). Secondary data was taken from electronic medical records such as patient characteristics (gender, age & 2nd prophylaxis), echocardiography data before PTMC (Wilkins’ score and MVA before PTMC), and echocardiography data after PTMC (MVA after PTMC). Follow-up echocardiography examination (follow-up MVA) and laboratory assessment of chronic inflammation marker (IL-6) were done on all patients. Statistical analyses were done to look for an association between the level of chronic inflammation marker & other independent variables with mitral valve restenosis. Results: Median IL-6 concentration was 2.39 (0.03 – 11.4) pg/mL. There was no statistically significant difference in IL-6 levels between both groups (p-value >0.05). MVA decrement was 0.13 (0 – 0.62) cm2/year with rate of MVA decrement ≥0.155 cm2/year was predictor of mitral valve restenosis (p-value <0.001, OR = 46.72, 95% CI 6.69 – 326.19). Conclusion: Chronic inflammation assessed by IL-6 was not associated with mitral valve restenosis.This article has a related Erratum.